Semagen 1mg Injection is a pharmaceutical preparation containing semaglutide, a GLP-1 receptor agonist used in the management of type 2 diabetes mellitus. This injectable medication works by stimulating insulin secretion in response to elevated blood glucose levels while simultaneously reducing glucagon secretion when blood sugar is low. Semagen helps improve glycemic control and may contribute to modest weight reduction in diabetic patients. Administered subcutaneously once weekly, it offers convenient dosing for enhanced treatment compliance. Suitable for patients requiring additional glycemic management beyond oral antidiabetic agents.

SEMAGEN 1MG INJ